InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Ribeiro Ramiro. Director active across 2 companies, notably EyePoint, Inc.. In total, 7 reports have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €58k. History available since 11 November 2025. The latest transaction was disclosed on 17 April 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Ribeiro Ramiro is a declarant linked to EyePoint, Inc. and EyePoint Pharmaceuticals, Inc., where he is Chief Medical Officer. He has 7 filings in total, and across the sampled recent filings from 2025-11-12 to 2026-04-20, sales total 58369 EUR, with the transaction nature listed as Option exercise.